1、北京市科委，科技新星项目，2024-09至2027-09，40万元，主持

2、北京市卫健委，医师科学家项目，2024-05至2025-04，50万元，主持

3、北京市卫健委，首发青年优才项目，2024-01至2026-12，26万元，主持

4、首都医科大学，优秀青年人才项目，2024-01至2026-12，90万元，主持

5、国家自然科学基金委员会, 青年项目，2022-01至2024-12，30万元，主持

6、北京市教育委员会，面上项目，2022-01至2024-12，15万元，主持

7、北京市医院管理局，青苗人才项目，2023-01至2024-12，14万元，主持

1）Wang Z, Du X*, Hua C, Li W, Zhang H, Liu X, Wang Y, Jiang C*, Guo J, LvQ, Anderson CS, Dong J, Ma C. The Effect of Frailty on the Efficacy and Safety of Intensive Blood Pressure Control. Circulation. 2023;148(7):565-574.  Q1区，IF=37.8，共同通讯

2）Jiang C#, Li S#, Wang Y, Lai Y, Bai Y, Zhao M, He L, Kong Y, Guo X, Li S, Liu N, Jiang C, Tang R, Sang C, Long D, Du X, Dong J, Anderson CS, Ma C. DiastolicBlood Pressure and Intensive Blood Pressure Control on Cognitive Outcomes.Hypertension. 2023;80(3):580-589.  Q1区，IF=8.3，第一作者

3）Wang J#, Jiang C#, Li S, Wang Z, Wang Y, Lai Y, Wang Z, Lv W, Bai Y, Yang Z, Guo Q, Huang L, He L, Guo X, Li S, Liu N, Jiang C, Tang R, LongD, Du X, Sang C, Dong J, Ma C. Systolic Blood Pressure Time in Target Range andIncident Atrial Fibrillation in Patients with Hypertension. Hypertension. 2023.Epub ahead of print.  Q1区，IF=8.3，共同一作

4）Li S#, Jiang C#, Wang Y, Lai Y, Zhao M, Li Q, Bai Y, Dai W, Guo Q, He L, Guo X, Wang W, Li S, Liu N, Jiang C, Tang R, Sang C, Long D, Du X, Dong J, Anderson CS, Ma C. Systolic Blood Pressure Time in Target Range and Cognitive Outcomes. Hypertension. 2023;80(8):1628-1636.  Q1区，IF=8.3，共同一作

5）Jiang C, Lai Y, Du X, Wang Y, Li S, He L, Hu R, Lv Q, Wu J, Feng L, Ning M, Ruan Y, LiX, Jia C, Dai W, Guo X, Jiang C, Tang R, Sang C, Long D, Arima H, Dong J, Anderson CS, Ma C. Effects of intensive blood pressure control on cardiovascular and cognitive outcomes in patients with atrial fibrillation.Europace. 2022;24(10):1560-1568.  Q1区，IF=6.1，第一作者

6）Li M#, Jiang C#, Lai Y, Wang Y, Zhao M, Li S, Peng X, He L, Guo X, Li S, Liu N, Jiang C, Tang R, Sang C, Long D, Du X, Dong J, Ma C.Genetic Evidence for Causal Association Between Atrial Fibrillation and Dementia: A Mendelian Randomization Study. J Am Heart Assoc.2023;12(16):e029623.  Q1区，IF=5.4，共同一作

7）Jiang C,Chen TG, Du X, Li X, He L, Lai YW, Xia SJ, Liu R, Hu YY, Li YX, Jiang CX, LiuN, Tang RB, Bai R, Sang CH, Long DY, Xie GT, Dong JZ, Ma CS. A simple and easily implemented risk model to predict 1-year ischemic stroke and systemic embolism in Chinese patients with atrial fibrillation. Chin Med J (Engl).2021;134(19):2293-2298.  Q1区，IF=6.1，第一作者

8）Wenjie L, Wang Z, Li M, Jiang C, Hua C, Tang Y, Zhang H, Liu X, Zheng S, Guo H, Zhao M, Wang YF, Gao M, Lv Q, Dong J, Ma CS, Du X. The Impact of frailty on the effectiveness of intensive blood pressure control for patients with type 2 diabetes: a secondary analysis of a randomised controlled trial. Heart. 2025 Feb 6:heartjnl-2024-324360. doi: 10.1136/heartjnl-2024-324360. Epub ahead of print. 共同通讯

9）Li J, Lai Y, Jiang C, Li M, Yang Z, Zhao M, Peng X, Li S, Li Q, Chen J, Wang Z, Zhang S, Ma C, Dong J. Fibroblast growth factor 23 and outcomes of atrial fibrillation: from clinical association to genetic evidence. Eur J Prev Cardiol. 2025 Jan 29:zwaf001. doi: 10.1093/eurjpc/zwaf001. Epub ahead of print. 共同通讯

10）Wang Z, Li M, Jiang C, Zhao M, Guo H, Lai Y, Wang Y, Gao M, Xia S, He L, Guo X, Li S, Liu N, Jiang C, Tang R, Zhou N, Sang C, Long D, Du X, Dong J, Ma C. Non-early catheter ablation vs drug therapy in atrial fibrillation: Results from the CABANA trial. Heart Rhythm. 2024 Nov 9:S1547-5271(24)03562-8. doi: 10.1016/j.hrthm.2024.11.010. Epub ahead of print. 共同通讯

11）Jiang C, Wang Z, Du X, Wang Y, Gao M, Jia Z, Chai Z, Yang Z, Wang C, He L, Hu R, Lv Q, Wu J, Li X, Jia C, Han R, Arima H, Wang X, Neal B, Rodgers A, Hillis GS, Patel A, Li Q, Dong J, Anderson CS, Ma C. Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: Rationale and design of the CRAFT trial. Am Heart J. 2024 Dec;278:33-40. 

12）Zhao Z, Wang Y, Jiang C, Yang Z, Zhang J, Lai Y, Wang J, Li S, Peng X, Li M, Li E, Guo H, Li J, Kong X, He L, Zuo S, Guo X, Li S, Liu N, Tang R, Sang C, Long D, Du X, He L, Dong J, Ma C. Impact of sodium-glucose cotransporter 2 inhibitor on recurrence and cardiovascular outcomes after catheter ablation for atrial fibrillation in patients with heart failure. Heart Rhythm. 2024 Aug 20:S1547-5271(24)03153-9. doi: 10.1016/j.hrthm.2024.08.034. Epub ahead of print. 共同通讯

13）Li W, Wang Z, Jiang C, Hua C, Tang Y, Zhang H, Liu X, Zheng S, Wang Y, Gao M, Lv Q, Dong J, Ma C, Du X. Effect of Intensive Blood Pressure Control on Cardiovascular Outcomes in Cancer Survivors. Hypertension. 2024 Mar;81(3):620-628. 共同通讯

14）Jiang C, Zhao M, Li M, Wang Z, Bai Y, Guo H, Li S, Lai Y, Wang Y, Gao M, He L, Guo X, Li S, Liu N, Jiang C, Tang R, Long D, Sang C, Du X, Dong J, Anderson CS, Ma C. Orthostatic blood pressure changes do not influence cognitive outcomes following intensive blood pressure control. J Intern Med. 2024 Apr;295(4):557-568.

15）Zhao Z, Jiang C, He L, Zheng S, Wang Y, Gao M, Lai Y, Zhang J, Li M, Dai W, Zuo S, Guo X, Li S, Jiang C, Liu N, Tang R, Long D, Du X, Sang C, Dong J, Ma C. Impact of Sodium-Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With Diabetes: A Propensity-Score Matching Study and Meta-Analysis. J Am Heart Assoc. 2023 Dec 19;12(24):e031269. 共同一作